Files

TaltavullTC.pdf (374.84 KB)

Document type

Article

Version

Published version

Publication date

2017-02-01

Publication license

cc by (c) Casanovas Taltavull, Teresa; Peña Cala, Maria Carmen, 2017
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/124486

Romiplostim therapy as a second‐line treatment before splenectomy for refractory immune thrombocytopenia in a cirrhotic patient with iatrogenic Cushing syndrome secondary to corticosteroids

Journal Title

Authors

Director/Tutor

Journal ISSN

Volume Title

Related resource

https://doi.org/10.1002/ccr3.667

Abstract

Key Clinical Message: Our case report discusses the usefulness of administering romiplostim as a second-line treatment before splenectomy in a cirrhotic patient with immune thrombocytopenia who developed corticosteroid-induced Cushing's syndrome. Corticosteroids were tapered and consequently withdrawn. The patient made a full recovery postsplenectomy.

Subject

Síndrome de Cushing, Administració de medicaments

Subject (English)

Cushing's syndrome, Administration of drugs

Citation

Collections

Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Citation

CASANOVAS TALTAVULL, Teresa and PEÑA CALA, Maria Carmen. Romiplostim therapy as a second‐line treatment before splenectomy for refractory immune thrombocytopenia in a cirrhotic patient with iatrogenic Cushing syndrome secondary to corticosteroids. Clinical Case Reports. 2017. Vol. 5, num. 2, pags. 159-163. [consulted: 15 of June of 2026]. Available at: https://hdl.handle.net/2445/124486

Export metadata

JSON - METS

Share record